Sensorineural hearing loss in sickle cell disease-A prospective study from Oman

2011 ◽  
Vol 121 (2) ◽  
pp. 392-396 ◽  
Author(s):  
Muhammed Hesham Al Okbi ◽  
Salam Alkindi ◽  
Rashid K. Al Abri ◽  
John Mathew ◽  
Afarida A. Nagwa ◽  
...  
1996 ◽  
Vol 16 (6) ◽  
pp. 641-644 ◽  
Author(s):  
Ibrahim A. Al-Dabbous ◽  
Ali H. Al Jam'a ◽  
Suresh K. Obeja ◽  
A. N. Raj Murugan ◽  
Haroun A. Hammad

1993 ◽  
Vol 107 (9) ◽  
pp. 790-794 ◽  
Author(s):  
S. O. Ajulo ◽  
A. I. Osiname ◽  
H. M. Myatt

AbstractSensorineural hearing loss (SNHL) has been a well-documented complication of sickle cell disease in the literature from West Africa, West Indies, United States of America and the Middle East. We present a study of 52 patients with homozygous sickle cell disease and 36 control patients with haemoglobin genotype AA, matched for age and sex. Seven patients with sickle cell disease (13.5 per cent) were found to have sensorineural hearing loss i.e.>20 dB at two or more frequencies, while all the patients in the control group had normal hearing (p<0.05).Our study shows the incidence of SNHL in the UK to be similar to that reported in the US A and much lower than that found in malaria endemic areas of the tropics.We highlight the factors which we consider responsible for these differences and suggest that the crucial period in the development of SNHL in sickle cell disease may be intra-uterine or during the first few years of life. All sickle cell patients should be encouraged to have regular hearing assessment.


2019 ◽  
Vol 118 ◽  
pp. 110-114 ◽  
Author(s):  
Annie N. Farrell ◽  
April M. Landry ◽  
Marianne E. Yee ◽  
Roberta M. Leu ◽  
Steven L. Goudy

2000 ◽  
Vol 21 (2) ◽  
pp. 75-79 ◽  
Author(s):  
Otavio Piltcher ◽  
Luciana Cigana ◽  
Joao Friedriech ◽  
Fernando de Andrade Quintanilha Ribeiro ◽  
Sady Selaimen da Costa

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Elina Kapoor ◽  
David Strum ◽  
Timothy Shim ◽  
Sunny Kim ◽  
Parisa Sabetrasekh ◽  
...  

Children ◽  
2021 ◽  
Vol 8 (2) ◽  
pp. 84
Author(s):  
Jeanne Sigalla ◽  
Nathalie Duparc Alegria ◽  
Enora Le Roux ◽  
Artemis Toumazi ◽  
Anne-Françoise Thiollier ◽  
...  

The majority of hospitalizations of patients with sickle cell disease (SCD) are related to painful vaso-occlusive crises (VOCs). Although the pain of VOC is classically nociceptive, neuropathic pain (NP) has also been demonstrated in SCD patients. The aim of our study is to specify the prevalence of NP during VOCs in SCD children using a dedicated scale and to measure its characteristics. We performed a prospective study that included SCD children hospitalized for an acute VOC. The presence of NP was sought with the DN4 scale on the second and fourth days of hospitalization. A total of 54 SCD children were included in the study. Overall, 41% of the patients (n = 22) experienced neuropathic pain during the VOC, mostly at an early stage (Day 2). The median age, the sex ratio, the location of the pain, and the morphine consumption were similar for patients with and without NP. Our study shows that neuropathic pain is very common during VOCs in SCD children. The absence of identified risk factors should prompt us to be vigilant regardless of the patient’s age, sex, and clinical presentation.


Sign in / Sign up

Export Citation Format

Share Document